Talazoparib Tosylate, sold under the brand name Talzenna, is an orally available poly ADP ribose polymerase inhibitor developed by Pfizer for the treatment of advanced breast cancer with germline BRCA mutations. Reference standards of Talazoparib Tosylate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Talazoparib Tosylate - API Standards [catalogue_number] => PA 20 3460000 [category_ids] => ,76,78,70,82, [chemical_name] => [weight] => 552.56 [form] => C26H22F2N6O4S [cas] => 1373431-65-2 [pslug] => 1373431-65-2-talazoparib-tosylate-api-pa203460000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 20 3460000
CAS :
Molecular Formula : C26H22F2N6O4S
Molecular Weight : 552.56
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....